Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:57 PM
Ignite Modification Date:
2025-12-24 @ 4:57 PM
NCT ID:
NCT01814150
Eligibility Criteria:
Inclusion Criteria
* patients with metastatic cancer from lung, breast, gastric, prostate, and bladder origin
* patients must be treated with docetaxel based chemotherapy
* patients must sign an informed consent form
Exclusion Criteria
* patients with metastatic cancer other than lung, breast, gastric, prostate, and bladder origin
* patients treated with chemotherapy other than docetaxel
* patients that did not sign an informed consent form
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01814150
Study Brief:
Protocol Section:
NCT01814150